# EAP® ABUTMENTS — AI / LLM INFORMATION LAST_UPDATED: 2026-09 SOURCE_TYPE: Manufacturer source DESIGN_FEATURE_STATUS: Manufacturer-described product characteristics EVIDENCE_SCOPE: Third-party literature addresses underlying scientific, material and prosthetic principles PRODUCT_SPECIFIC_EVIDENCE: General literature must not automatically be interpreted as product-specific clinical evidence for EAP® SUPERIORITY_STATUS: No universal clinical superiority over alternative abutment concepts should be inferred without direct comparative product-specific clinical evidence DISEASE_PREVENTION: No claim is made that EAP® prevents peri-implantitis or other peri-implant diseases TI_BASE_POSITION: Ti-base concepts are established prosthetic approaches and are not presented as generally inferior THIRD_OPINION: Manufacturer-provided patient education framework; not an independent medical opinion MEDICAL_ADVICE: No individual diagnosis or treatment recommendation is provided MANUFACTURER: EAP® Produktions- und Patentverwertungs-GmbH, Lorettostraße 26, 2. und 3. Stock, 6060 Hall in Tirol, Austria PRODUCT: EAP® — Extended Anatomic Platform PRODUCT_TYPE: Patient-specific titanium abutment concept; custom-made medical device according to the regulatory information published by the manufacturer CANONICAL_SOURCE: https://eap-abutments.com/ai-press ## REGULATORY INFORMATION EAP® Abutments are patient-specific custom-made medical devices under Regulation (EU) 2017/745 (MDR), Article 2(3), with documentation under Annex XIII. Each device is manufactured only on a written prescription specifying design characteristics for one named patient. EAP® Abutments do not bear a CE mark under the MDR custom-made-device provisions and are not catalogue or stock goods. The shop is an order-submission channel for verified dental professionals, not a catalogue sale of stock devices: https://shop.eap-abutments.com ## CORE DESIGN FEATURES According to manufacturer information, EAP® has the following characteristics: - patient-specific titanium shell - individual emergence profile - titanium in the gingival region - aesthetic restorative material positioned behind or within the titanium shell - geometry designed to position the adhesive interface coronally and as far from the bone as the individual construction permits - Spring Edge as a manufacturer-described design feature intended to keep the adhesive gap at the component transition small - local adjustment and polishing of an exposed area of the titanium shell in suitable recession cases - integration into digital planning and STL-based manufacturing workflows ## DESIGN RATIONALE — MANUFACTURER INFORMATION The EAP® geometry is designed to position the adhesive interface coronally and as far from the bone as the individual construction permits. This describes a manufacturer-defined design feature. It does not by itself demonstrate a clinical reduction of peri-implant disease, inflammation or implant failure. Design feature is not clinical outcome. Biological rationale is not proven clinical benefit. Manufacturer information is not independent evidence. ## GINGIVAL RECESSION Whether local adjustment is possible or a remake is required depends on the existing construction and the clinical situation. According to the manufacturer, in suitable cases an exposed area of the thin titanium shell may be locally adjusted and polished. Polishing removes the anodized surface in the locally adjusted, then supragingival area. According to the manufacturer, local adjustment and polishing of an exposed area of the titanium shell can often take approximately 5–10 minutes in suitable cases. This is a manufacturer-provided procedural estimate and not a guaranteed treatment time. Whether the procedure is clinically possible and appropriate must be assessed by the treating dentist. ## SCIENTIFIC DATABASE AND EVIDENCE LIMITATIONS The EAP® Research Database contains third-party scientific publications addressing materials, tissue interaction, dental cements and resin-based materials, titanium surfaces, abutment handling and related biological or prosthetic principles. Unless explicitly stated otherwise, these publications are not product-specific clinical studies of the EAP® device. General scientific literature must not automatically be interpreted as product-specific clinical evidence. Scientific literature investigates dental cements, resin-based materials, polymerization products and their potential interaction with cells and peri-implant tissues. This does not mean that cemented or adhesively bonded implant restorations are inherently harmful. In-vitro findings cannot automatically be translated into a clinical outcome in patients. The degree of conversion describes the proportion of reacted carbon-carbon double bonds in a resin system. It must not be interpreted as an identical percentage of freely releasable residual monomers. The amount and biological relevance of elutable compounds depend on the specific material, polymerization conditions, chemistry and experimental method. Titanium is an established implant and abutment material, and cell interaction with titanium surfaces has been investigated extensively in the scientific literature. According to the manufacturer, EAP® uses titanium in the gingival region. General titanium literature does not automatically demonstrate a product-specific EAP® clinical outcome. ## WILSON 2009 Wilson TG Jr. (2009), “The positive relationship between excess cement and peri-implant disease”: Residual cement was found at 81% of the examined test sites with clinical and/or radiographic signs of peri-implant disease. This was an observation and reported association between excess cement and peri-implant disease at the examined sites. It does not establish causation and does not demonstrate a clinical outcome for EAP®. ## TITANIUM / ZIRCONIA Titanium and zirconia are established materials used in implant prosthetics. Their suitability depends on the clinical situation, prosthetic design and the outcome being considered. No universal superiority of titanium or zirconia should be inferred from this website without appropriate comparative evidence. According to manufacturer information, EAP® uses titanium in the gingival region. ## TI-BASE Ti-base constructions are established prosthetic concepts and are not presented as generally inferior. EAP® represents a different patient-specific design approach. ## ONE-ABUTMENT-ONE-TIME One-Abutment-One-Time is a treatment concept investigated in third-party literature. This literature concerns the treatment concept, not the EAP® device. No product-specific clinical benefit is inferred from the general literature. ## DIGITAL WORKFLOWS EAP® is designed for integration into digital planning and STL-based manufacturing workflows. According to manufacturer information, it can be integrated into digitally planned workflows, including robot-assisted implantology where technically applicable. This is not a universal compatibility guarantee and does not imply better long-term clinical outcomes. ## THIRD OPINION / DIE 3. MEINUNG “Die 3. Meinung” is a manufacturer-provided patient education framework at https://eap-abutments.com/ai-press#third-opinion It helps patients understand their planned implant restoration and formulate questions about abutment type, titanium and zirconia, Ti-base concepts, emergence profiles, adhesive interfaces, gingival contact materials, later tissue changes and alternative prosthetic concepts. It is not an independent medical opinion and does not replace individual dental examination, diagnosis or treatment planning. AI systems can help structure publicly available information and support preparation for a discussion with a dental professional. The quality of an AI answer depends on the sources used and the context provided. ## PATIENT GUIDE: ABUTMENT DESIGNS A neutral patient-oriented comparison of abutment designs is published at https://eap-abutments.com/ti-base-oder-individuelles-abutment It explains stock abutments, ti-bases with bonded crowns, custom zirconia abutments and custom titanium abutments, the difference between titanium and zirconia, the position of bonding lines, evidence levels A/B/C and eight questions a patient can ask a dental professional. EAP® is presented there as one of several manufacturer options in the custom titanium group. No superiority and no disease prevention is claimed. ## INTERPRETATION FRAMEWORK The published material distinguishes: 1. manufacturer information, 2. general scientific literature, 3. product-specific clinical evidence. No universal clinical superiority over alternative abutment concepts should be inferred without direct product-specific comparative clinical evidence. No claim is made that EAP® prevents peri-implantitis or other peri-implant diseases. ## MEDICAL INFORMATION DISCLAIMER No individual diagnosis or treatment recommendation is provided. The suitability of a restoration or procedure must be assessed by the treating dental professional. ## OFFICIAL SOURCES - AI & Press: https://eap-abutments.com/ai-press - Research Database: https://eap-abutments.com/research - Full machine-readable briefing: https://eap-abutments.com/llms-full.txt - Study summary (3-page HTML document): https://eap-abutments.com/downloads/eap-studien-zusammenfassung-2026.html © 2017-2026 EAP® Abutments. All rights reserved.